lactic acid has been researched along with (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 1 (16.67) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 1 (16.67) | 2.80 |
Authors | Studies |
---|---|
Eagles, CJ; Kendall, MJ | 1 |
Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M; Otsuka, Y | 1 |
Atsuta, I; Ayukawa, Y; Jinno, Y; Koyano, K; Masuzaki, T; Moriyama, Y; Ogino, Y | 1 |
Atsuta, I; Ayukawa, Y; Furuhashi, A; Koyano, K; Masuzaki, T; Moriyama, Y; Rakhmatia, YD; Yasunami, N | 1 |
Akasaki, Y; Ayukawa, Y; Goto, N; Ishihara, K; Koyano, K; Masuzaki, T; Murakami, K; Nakashima, Y; Okazaki, K; Yasunami, N | 1 |
Bellosta, S; Castiglioni, S; Cilurzo, F; Magri, G; Procacci, P; Puoci, F; Rizzello, L; Rossi, C; Sartori, P; Scarpa, E; Selmin, F; Tolva, V | 1 |
1 trial(s) available for lactic acid and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
The effects of combined treatment with beta 1-selective receptor antagonists and lipid-lowering drugs on fat metabolism and measures of fatigue during moderate intensity exercise: a placebo-controlled study in healthy subjects.
Topics: Adrenergic beta-Antagonists; Adult; Ammonia; Analysis of Variance; Anticholesteremic Agents; Atenolol; Bezafibrate; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Energy Metabolism; Exercise; Fatigue; Fatty Acids, Monounsaturated; Fatty Acids, Nonesterified; Female; Fluvastatin; Heart Rate; Humans; Hypolipidemic Agents; Indoles; Lactic Acid; Lipids; Male; Oxygen Consumption; Triglycerides | 1997 |
5 other study(ies) available for lactic acid and (3S,5S,6E)-7-[3-(4-fluorophenyl)-1-(propan-2-yl)-1H-indol-2-yl]-3,5-dihydroxyhept-6-enoic acid
Article | Year |
---|---|
Inhibitory effects of statins on human monocarboxylate transporter 4.
Topics: Animals; Atorvastatin; Basigin; Fatty Acids, Monounsaturated; Fluvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lactic Acid; LLC-PK1 Cells; Lovastatin; Monocarboxylic Acid Transporters; Muscle Proteins; Pyridines; Pyrroles; Simvastatin; Swine; Transfection | 2006 |
The effect of a single remote injection of statin-impregnated poly (lactic-co-glycolic acid) microspheres on osteogenesis around titanium implants in rat tibia.
Topics: Animals; Fatty Acids, Monounsaturated; Female; Fluvastatin; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Lactic Acid; Microscopy, Electron, Scanning; Microspheres; Osteogenesis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Prostheses and Implants; Rats; Rats, Sprague-Dawley; Tibia; Titanium | 2010 |
Acceleration of hard and soft tissue healing in the oral cavity by a single transmucosal injection of fluvastatin-impregnated poly (lactic-co-glycolic acid) microspheres. An in vitro and rodent in vivo study.
Topics: Absorption, Physicochemical; Animals; Anticholesteremic Agents; Bone Development; Capsules; Connective Tissue; Diffusion; Fatty Acids, Monounsaturated; Fluvastatin; In Vitro Techniques; Indoles; Lactic Acid; Materials Testing; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rats; Rats, Wistar; Tooth Socket; Treatment Outcome; Wound Healing | 2015 |
Single intra-articular injection of fluvastatin-PLGA microspheres reduces cartilage degradation in rabbits with experimental osteoarthritis.
Topics: Animals; Anticholesteremic Agents; Arthritis, Experimental; Cartilage, Articular; Chondrocytes; Drug Evaluation, Preclinical; Fatty Acids, Monounsaturated; Female; Fluvastatin; Humans; Indoles; Injections, Intra-Articular; Lactic Acid; Microspheres; Osteoarthritis; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Primary Cell Culture; Rabbits | 2017 |
Caffeic Acid-Grafted PLGA as a Novel Material for the Design of Fluvastatin-Eluting Nanoparticles for the Prevention of Neointimal Hyperplasia.
Topics: Drug Carriers; Endothelial Cells; Fluvastatin; Humans; Hyperplasia; Lactic Acid; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer | 2022 |